Key points are not available for this paper at this time.
The PET/CT-based DLR model accurately differentiates benign from malignant lymph nodes, outperforming conventional methods. Combining DenseNet121-derived features with radiomics improves staging accuracy and aids personalized treatment planning.
Duan et al. (Wed,) studied this question.